Somite Therapeutics Appoints Prof. Jay Shendure As Scientific Co Founder
May 21, 2024•about 1 year ago
Position
Founder
Company
Somite
Description
Somite Therapeutics is thrilled to announce the addition of Prof Jay Shendure as its newest Scientific Co-Founder. Prof Shendure, an HHMI Investigator and world leader in single-cell and functional genomic assays, will help advance Somite's AI platform, AlphaStem, to develop cell replacement therapies for various diseases.
FundzWatch™ Score
82
Medium Activity
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months